Legal and Policy Challenges for the Coverage of and Payment for Cell and Gene Therapies (On-Demand Webinar)

Register

Date: 01/24/24

Closed captions are available.

Overview: In this webinar, the speakers address legal and policy issues related to coverage and reimbursement of cell and gene therapies in the United States.  The speakers discuss issues such as federal requirements requiring coverage of such drugs, limitations on reimbursement, and legal restrictions on innovative payment arrangements.  The webinar also focuses on challenges in both the Medicare, Medicaid and commercial markets.  The presentation concludes with a discussion of proposed policy solutions and their potential impacts.

Learning Objectives: 

  • Understand the legal framework for payers’ coverage and reimbursement for cell and gene therapies.
  • Develop insight into the key challenges for the Medicaid, Medicare, and commercial payer segments
  • Develop familiarity with proposals intended to promote access to these therapies and their costs and benefits.

Speaker Information:

Alex Dworkowitz, Partner, Manatt, Phelps & Phillips, LLP

Kristin Wolff, Vice President, Market Access, Bluebird Bio

 

Continuing Education:

CLE: The maximum number of credits available for ON DEMAND is 1.5 for a 60-minute state and 1.8 for a 50-minute state. Please note that the availability of credits may vary from state to state.  This self-study course will be available for purchase for approximately one year after the recording date, but state rules on duration of eligibility for CLE-credits differ, so please check with your state before purchasing self-study offerings. 

CPE: CPE credits are not available for on-demand. 

CCB: CCB Credits are not available for this on-demand webinar.

For additional information, please visit the AHLA Continuing Education page. 

Register